Abdullah Al Mamun Khan
Department of Medical Oncology, ‘Shaheed Suhrawardy Medical College, BangladeshFulltext PDF
Background: Breast cancer is the second most common cause of cancer related death worldwide. It involves patient physical health, mental health, family and social life and wastes financial and spiritual resources and its cure depend on staging at diagnosis and management plan depend to their economics especially in developing countries. Methods: The study was an observational study. All breast cancer patients in National Institute of cancer research and hospital and Shaheed Suhrawardy Medical College from January 2010 to December 2019 were included. Results: Of total 6,622, male was 234 (3.53%), female 6,388 (94.47%). Lowest age of breast cancer diagnosis was 12 year, highest 95 and average age was 48.7 year. The leading age group was 40 to 49 year 2,346 (35.43%). None were diagnosed as Noninvasive breast cancer. Only 792 (12%) patient had immunohistochemistry report, TNBC were 294 (37.12%), the leading variety. Mostly 2,685 (40.55%) patient presented with metastatic disease. Early breast cancer diagnosis was 3,405 (51.42%). Postmenopausal was 4,082 (64%), 4,649 (70%) was poor, 3,582 (54%) was illiterate, 1,268 (27.75%) were educated up to primary, 4,902 (74%) were housewife. Hormonal contraception used 4,258 (64.31%), 1,994 (30.11%) used betel-nut or tobacco, 1,669 (25%) had comorbidity, 895 (14.16%) were nallipara, 2,543 (40.86%) had para 1 and 632 (9.54%) had positive family history of cancer. Maximum patient 2,023 (30.55%) were on chemotherapy, 1,497 (22.64%) had simple mastectomy, 1,335 (20.16%) were on homeopathy, 790 (11.93%) had modified radical mastectomy, 772 (11.66%) were without treatment, 512 (7.73) had breast conservation surgery. Conclusion: Screening should give priority in developing country like Bangladesh to diagnose the disease early to cure the disease.
Al Mamun Khan A. Risk Factors and Barriers of Early Breast Cancer Diagnosis and Treatment Outcome in Tertiary Level Hospitals in Bangladesh. Jpn J Cancer Oncol Res. 2021; 4(1): 1010.